1-3 of 3
Armando V. Mena-Duran, MD
Close
Sort by
Journal Articles

SHP-1 (PTPN6) Gene Supression by FLT3/ITD Defines an Aggressive Subgroup of Myeloid Malignancies.

Armando V. Mena-Duran, MD, Juan C. Pajuelo, MSc, Jose Cervera-Zamora, MD, Zaida Garcia-Casado, PhD, Ana Valencia, MSc, Eva Barragan, PhD, Luis Benlloch, BSc, Tomas Mustelin, MD,PhD, Guillermo Sanz, MD,PhD, Miguel A. Sanz, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1907.
https://doi.org/10.1182/blood.V108.11.1907.1907
Published: 2006
Journal Articles

Identification of Risk Factors for Tumour Lysis Syndrome in Patients with Acute Myeloid Leukaemia: Development of a Prognostic Score.

Pau Montesinos, MD, Guillermo Martin, MD, Mariluz Perez-Sirvent, MD, Armando V. Mena-Duran, MD, Ignacio Lorenzo, MD, Martinez Jesus, MD, Javier De La Rubia, MD, Noemi Puig, MD, Susana Cantero, MD, Jaime Sanz, MD, Carlos Pastorini, Guillermo F. Sanz, MD, Miguel A. Sanz, MD
Journal: Blood
Blood (2005) 106 (11): 1843.
https://doi.org/10.1182/blood.V106.11.1843.1843
Published: 2005
Journal Articles

Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.

Guillermo F. Sanz, MD, Armando V. Mena-Duran, MD, Jose M. Ribera, MD, Teresa Bernal, MD, Luis Palomera, MD, Maria C. del Cañizo, MD, Mar Tormo, MD, Maria J. Sayas, MD, Raimundo García-Boyero, MD, Javier de la Serna, MD, Manuel Pérez-Encinas, MD, Montserrat Pérez-Sánchez, MD, María J. Arilla, MD, Juan J. Moneva, MD, Maria L. Amigo, MD, Luis Benlloch, Montserrat Batlle, MD, Consuelo Rayon, MD
Journal: Blood
Blood (2005) 106 (11): 793.
https://doi.org/10.1182/blood.V106.11.793.793
Published: 2005